ArticleFrontiers in surgery2025
Machine learning to predict the occurrence of complications after total shoulder arthroplasty for B2-B3 glenoids.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Total shoulder arthroplasty (TSA) for primary glenohumeral osteoarthritis with B2-B3 glenoids is challenging due to the relatively high rate of postoperative complications, such as glenoid implant loosening. Machine learning (ML) is a promising method for predicting outcomes in shoulder arthroplasty. However, no studies have included preoperative radiological data to predict surgical complications using ML. The present study evaluated the potential of ML in predicting the occurrence of complications after TSA in patients treated for glenohumeral osteoarthritis with B2-B3 glenoids by integrating various prognostic factors, such as radiological features. We hypothesized that ML would accurately predict postoperative complications and identify the variables that are most strongly associated with these complications. Materials and methods: This retrospective study included 60 patients with primary osteoarthritis and type B2-B3 glenoids from our institutional TSA database. Prognostic factors, including patient characteristics, clinical scores, radiological features, and surgical techniques, were recorded. Outcomes at a minimum of 2 years of follow-up were characterized by the Aldinger complication scale (scored 0-III). Of the 60 patients, 13 (21.7%) experienced complications, with 8 (13.3%) classified as Aldinger I and 5 (8.3%) as Aldinger III. These data were used to train and test four ML methods: logistic regression (LR), gradient boosting classifier (GBC), support vector machine (SVM), and multilayer perceptron classifier (MLPC). We considered a binary outcome: no complication vs. Aldinger I-III. The data were split into a training set (75%) and a testing set (25%). Results: Among the four ML models evaluated, LR and GBC correctly identified all complication cases (3/12), whereas SVM and MLPC missed one complication. The number of false positives was lower with GBC (2/12) and LR (3/12). Younger age, glenoid version and inclination were the main variables associated with complications. Using a posteriorly augmented glenoid implant was associated with lower complication rates. Conclusion: ML can efficiently predict TSA complications, even with a limited dataset. Glenoid retroversion was identified as a critical radiological feature associated with outcomes, as supported by the literature. In addition, younger age is associated with increased complication risks, likely due to increased functional demand. Thus, ML is potentially a valuable tool for forecasting complications in the surgical decision-making process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.